Chronic Fatigue Syndrome patients have major Natural Killer Cell problems: Do they need NK boosters for covid-19?
"Scientists demonstrated two decades ago that a deficiency of NK cells in patients infected with the SARS coronavirus was associated with more severe disease and the presence of SARS-specific antibodies. NK cell therapy is a deployable, rapidly scalable approach to treating Covid-19. And it’s well-established that immunotherapy can enhance vaccine-induced immunity."
Source:
https://www.diamandis.com/blog/augmenting-immunity-covid-19